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Impact of thrombus burden in ST-segment 






We aimed to determine whether the burden of angiographically observed thrombus is 
associated with impaired myocardial reperfusion and all-cause mortality in patients with 
ST-segment Elevation Myocardial Infarction (STEMI). In a sub-analysis, we investigated the 
effect of thrombus aspiration in patients with large and with small thrombus burden.
Background
Limited data is available regarding the impact of thrombus burden on myocardial reperfusion 
and mortality in STEMI patients. 
Methods
Of all consecutive STEMI patients treated with primary percutaneous coronary intervention 
between January 2004 and April 2010 we analyzed the coronary angiograms and collected 
mortality up to June 2014. 
Results 
Of the 2969 patients included, 68% had large (Thrombolysis In Myocardial Infarction 
thrombus score 4 or 5) and 32% small thrombus burden. Myocardial Blush Grade (MBG) 
0/1 and 1-year mortality were higher in patients with large compared to patients with small 
thrombus burden (34% vs. 21% p<0.001 and 9.2% vs. 6.7% p=0.017). The presence of MBG 
0/1 was lower when thrombus aspiration was performed, irrespective of whether the visible 
thrombus burden was large (31% vs. 38%, p=0.001) or small (18% vs. 25%, p=0.017). 
Conclusions
Large thrombus burden is associated with impaired myocardial perfusion and 1-year 
mortality in STEMI patients. Irrespective of thrombus burden visible on angiography, 





A large proportion of patients with ST-segment Elevation Myocardial Infarction (STEMI) have 
impaired myocardial perfusion despite a patent epicardial vessel after primary Percutaneous 
Coronary Intervention (PCI).1,2 Distal embolization visible at angiography leads to worse 
outcomes and is associated with larger thrombus burden.3,4 However, the high incidence 
of impaired myocardial perfusion cannot be explained by the relatively low incidence of 
angiographically visible distal embolization.4,5 Impaired myocardial perfusion is assumed 
to be caused by, angiographically undetectable, microembolization and microvascular 
occlusion.6,7 Nevertheless, whether myocardial perfusion caused by microembolization is 
also related to angiographically visible thrombus burden remains to be established.8 Also 
whether the potential beneficial effects of thrombus aspiration on myocardial perfusion 
might be associated with angiographically visible thrombus burden remains unclear.9-14 In 
this study, we sought to determine whether angiographically visible thrombus burden is 
associated with impaired myocardial perfusion and mortality in patients presenting with 
STEMI. Furthermore, we evaluated whether the beneficial effects of thrombus aspiration 
are depending on thrombus burden.
Methods
Study population and design
All consecutive STEMI patients treated with primary PCI at the University Medical Center 
Groningen in the Netherlands were included in our database. For this retrospective 
study, we analyzed data of STEMI patients admitted from January 2004 to April 2010. The 
criteria for STEMI were the following; ST-segment elevation of >0.1mV in ≥2 leads on the 
electrocardiogram, and onset of symptoms less than 12 hours or less than 24 hours with 
persisting symptoms due to ongoing ischemia. The criterion for primary PCI was successful 
crossing of the culprit lesion with a guidewire. From January 2004 until December 2004, 
STEMI patients were treated with conventional PCI (mainly balloon angioplasty followed 
by stent implantation). From January 2005 until December 2006, conventional PCI and 
thrombus aspiration followed by stent implantation were randomly performed in the 
context of TAPAS (Thrombus Aspiration during Percutaneous coronary intervention in 
Acute myocardial infarction Study).10,15 Manual thrombus aspiration became the preferred 
treatment since December 2006, but the choice of procedure was left to the discretion 
of the operator. Acute pharmacotherapy was according to current international guidelines, 
including heparin, aspirin, clopidogrel and the glycoprotein IIb/IIa inhibitor abciximab.16,17 
All coronary angiograms were analyzed by either an independent core laboratory or by two 
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experienced observers blinded to all clinical data.
Thrombus burden
Patients were included when thrombus burden was assessable on the angiogram before 
PCI. Thrombus burden was graded from 0 to 5 according to the Thrombolysis In Myocardial 
Infarction (TIMI) thrombus grade.18 The definitions are as follows; TIMI thrombus grade 
0, no angiographic characteristics of thrombus; grade 1, possible thrombus with reduced 
contrast density, haziness, irregular lesion contour or smooth convex ‘meniscus’ at the site 
of total occlusion suggestive but not diagnostic of thrombus; grade 2, definitive thrombus 
with greatest dimension ≤1/2 vessel diameter; grade 3, definitive thrombus with greatest 
dimension >1/2 but <2 vessel diameters; grade 4, definitive thrombus with greatest 
dimension ≥2 vessel diameters and grade 5, total occlusion. In this study, small thrombus 
burden was defined as TIMI thrombus grade ≤3 and large thrombus burden as TIMI thrombus 
grade ≥4. When assessable, thrombus burden was also graded after the first intervention: 
thrombus aspiration or balloon angioplasty. 
Definitions
Myocardial Blush Grade (MBG) was determined by the contrast density of the myocardial 
region of the infarct-related artery compared to the myocardial regions of non-infarct-
related arteries. MBG was classified as MBG 0, no myocardial blush or persisting blush 
(staining); MBG 1, minimal myocardial blush; MBG 2, moderate myocardial blush or MBG 
3, normal myocardial blush.19  Impaired myocardial perfusion is defined as a MBG of 0 or 1. 
TIMI flow grade was classified as previously described.20 Distal embolization was defined as 
angiographically visible filling defect and/or abrupt cut-off of the vessel distal to the culprit 
lesion.6 ST-segment resolution was defined as more than 70% resolution of the ST-segment 
deviation on the electrocardiogram at presentation compared to the electrocardiogram at 
30 to 60 minutes after primary PCI.21 Thrombus aspiration was classified as effective when 
macroscopic atherothrombotic material was identified in the retrieved aspirate. In May 2014 
mortality data was collected using the municipal civil registry, which contains completeness 
of vital status of all residents registered in The Netherlands.
Statistical analysis
Normally distributed continuous variables are presented as mean with standard deviation 
(SD) and were compared using a two-tailed Student’s t-test. Skewed distributed continuous 
variables are presented as median with interquartile range (IQR) and were compared using 
a Mann Whitney U test. Categorical variables are presented as number and percentage 
and were compared using the χ2 test or Fisher’s exact test. Kaplan Meier curves were used 




significance was defined as a two-sided p-value of less than 0.05. Statistical analysis was 
performed using SPSS software version 22.0 (Chicago, USA). 
Results
Large versus small thrombus burden
A total of 2991 patients presenting with STEMI were treated in our hospital with primary PCI. 
Of 2969 (99%) patients in whom the thrombus burden could be assessed on the coronary 
angiogram, 2023 (68%) patients had large thrombus burden and 946 (32%) patients had 
small thrombus burden (Figure 1). At baseline, patients with large thrombus burden had less 
diabetes mellitus, longer median ischemic time, more frequent the right coronary artery as 
culprit and more frequent an impaired TIMI flow (Table 1). 
 The impact of thrombus burden on angiographic, electrocardiographic and clinical 
outcomes is shown in Table 2. Angiographically visible distal embolization after PCI was seen 
more often in patients with large versus patients with small thrombus burden (15% versus 
5%, p<0.001). MBG could be assessed in 2775 (93%) patients. Impaired myocardial perfusion 
was significantly higher in patients with large versus patients with small thrombus burden 
(34% versus 21%, p<0.001) (Table 2 and Figure 2). TIMI flow grade 3 after PCI was also lower 
in patients with large thrombus burden. Even in patients with TIMI flow grade 3 after PCI, 
the incidence of impaired myocardial perfusion was higher in patients with large compared 
2991 consecuti ve STEMI pati ents treated with 
primary PCI between January 2004 and April 2010
2969 pati ents with assessable 
angiograms for thrombus burden
2023 pati ents with 
large thrombus burden
1179 fi rst interventi on 
thrombus aspirati on
529 fi rst interventi on 
thrombus aspirati on
946 pati ents with 
small thrombus burden
STEMI pati ents were classifi ed based on their thrombus burden observed angiographically and whether they 
were treated with thrombus aspirati on as fi rst interventi on.
STEMI: ST-segment Elevati on Myocardial Infarcti on.
Figure 1 | Flow chart
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to patients with small thrombus burden (22% vs. 16%, p<0.001). Finally, the incidence of ST-
segment resolution was lower in patients with large thrombus burden. 
During the median follow-up time of 6.6 years (IQR 4.9-8.4), 21.7% of the 2969 patients 
died. All-cause 1-year mortality was higher in patients with large versus patients with small 







Age, years 64±13 64±13 0.942
Male sex 1467 (73) 660 (70) 0.122
History
    Hypertension 723 (40) 333 (38) 0.358
    Diabetes mellitus 219 (11) 129 (14) 0.032
    Hypercholesterolemia 499 (30) 232 (28) 0.478
    Myocardial infarction 181 (9) 97 (11) 0.308
    PCI 161 (8) 71 (8) 0.650
    CABG 56 (3) 28 (3) 0.779
Current smoking 883 (50) 430 (51) 0.472
Body mass index, kg/m2 27.0±4 26.7±4 0.071
Cardiovascular disease in family 811 (46) 391 (45) 0.795
Ischemic time, minutes 190 (135-300) 180 (130-270) 0.010
Angiographic
Infarct-related artery <0.001
    Left anterior descending 807 (40) 468 (50)
    Circumflex 303 (15) 163 (17)
    Right coronary artery 875 (43) 284 (30)
    Other 38 (2) 31 (3)
TIMI flow grade <0.001
    0 or 1 1781 (88) 85 (9)
    2 or 3 241 (12) 857 (91)
Multivessel disease 1266 (63) 566 (60) 0.173
Procedural
Administration of glycoprotein IIb/
IIIa inhibitor 1735 (86) 807 (85) 0.741
Thrombus aspiration 1179 (58) 529 (56) 0.225
Data are presented as mean±SD, median (IQR) or as number (%).
PCI: percutaneous coronary intervention, CABG: coronary artery bypass grafting, TIMI: Thrombolysis In 
Myocardial Infarction.




Data are presented as number (%). 
* Data were available in 1205 pati ents with large and 641 pati ents with small thrombus burden.








    0 or 1 646 (34) 181 (21)
    2 or 3 1252 (66) 696 (79)
TIMI fl ow grade <0.001
  <3 414 (21) 81 (9)
    3 1602 (79) 856 (91)
Visible thrombus 117 (6) 17 (2) <0.001
Distal embolizati on 276 (15) 41 (5) <0.001
Side branch occlusion 42 (2) 14 (1) 0.261
Electrocardiographic
Complete ST-segment resoluti on* 623 (52) 434 (68) <0.001
Follow-up
30 days mortality 137 (6.8) 36 (3.8) 0.001
1-year mortality 187 (9.2) 63 (6.7) 0.018
MBG 0 or 1 was signifi cantly higher in pati ents with large thrombus burden versus pati ents with small thrombus 































Figure 2 | MBG related to large and small thrombus burden
Table 2 | Outcome characteristi cs in STEMI cohort
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long term follow-up; mortality of 21.6% in patients with large versus 21.7% in patients with 
small thrombus burden (logrank p=0.779) (Figure 3). 
Impact of thrombus aspiration
Thrombus aspiration as first intervention was performed in 1708 patients; 1179 (58%) 
patients with large and 529 (56%) with small thrombus burden, respectively (Table 1). Overall, 
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All-cause mortality rate was significantly higher in patients with large thrombus burden versus patients with small 
thrombus burden at 30-days and 1-year, but this disappeared during long term follow-up.




aspiration was performed compared to when no thrombus aspiration was performed. 
When the effect of thrombus aspiration on myocardial perfusion was evaluated separately 
in patients with large and small thrombus burden this finding remained unchanged. In 
patients with large thrombus burden, impaired myocardial perfusion was seen in 31% of 
patients after thrombus aspiration and in 38% after conventional PCI (p=0.002). In patients 
with small thrombus burden this was seen in 18% of patients after thrombus aspiration and 
in 25% after conventional PCI (p=0.018) (Figure 4). 
TIMI flow grade 3 after PCI was also more often seen when thrombus aspiration was 
performed compared to when no thrombus aspiration was performed in patients with 
large thrombus burden (85% versus 72%, p<0.001). However, in patients with small 
thrombus burden we did not observe a difference (93% versus 90%, p=0.130). There was 
no impact of thrombus aspiration on angiographically visible distal embolization compared 
to no thrombus aspiration as first intervention (in large thrombus burden 14% versus 
16%, p=0.142, in small thrombus burden 6% versus 3% p=0.100). In 1535 (90%) patients, 
thrombus burden was prospectively scored before and after the first intervention. In 1408 
(92%) of these patients with thrombus observed before PCI, reduction of thrombus burden 
with ≥1 TIMI thrombus grade was observed in 911 (87%) patients after thrombus aspiration 
and in 329 (90%) patients after balloon angioplasty as first intervention (p=0.211).
Retrieval of atherothrombotic burden













































MBG 0 or 1 was signifi cantly lower when thrombus aspirati on was performed, irrespecti ve of whether pati ents 
had large or low thrombus burden (p<0.05). 
MBG: Myocardial Blush Grade.
Figure 4 | Impact of thrombus aspirati on on MBG related to large and small thrombus burden
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was documented, after thrombus aspiration as first intervention. Thrombus aspiration was 
effective in 880 (86%) patients with large thrombus burden. In patients with small thrombus 
burden, thrombus aspiration was effective in 361 (75%) patients, of which 150 (71%) patients 
with no angiographically observed thrombus. Histopathological analysis was performed in 
369 patients. Patients with large thrombus burden had larger retrieved aspirate and more 
erythrocyte components in the aspirate than patients with small thrombus burden (Table 3).
Discussion
Our observational study suggests that an angiographically visible large thrombus burden 
is associated with impaired myocardial perfusion, worse TIMI flow after PCI, more distal 
embolization, less complete ST-segment resolution and higher 1-year, but not long-term 
mortality. Reducing thrombus burden by thrombus aspiration is associated with improved 
myocardial perfusion, irrespective of thrombus burden. 
Large versus small thrombus burden
We assume that the association between large thrombus burden and impaired myocardial 
perfusion can be explained by distal embolization. Impaired myocardial perfusion is thought 
to be mainly caused by embolization of particles of the atherothrombotic burden or vessel 
wall into the microvasculature.7,22 This embolization can occur spontaneously or by iatrogenic 
mobilization as part of the thrombolysis or PCI.7,22 Previous studies have suggested that large 
atherothrombotic burden before PCI increases the risk for embolization of atherothrombotic 
particles.4,5 In this observational study, we indeed observed a higher incidence of distal 
embolization in patients with large thrombus burden. Since impaired myocardial perfusion 






Retrieved aspirate* 880 (86) 361 (75) <0.001
Histopathological analysis 244 125
    Size <0.5mm 110 (45) 90 (72) <0.001
    0.5-2.0mm 72 (30) 25 (20)
    >2.0mm 62 (25) 10 (8)
Erythrocyte component 75 (31) 4 (3) <0.001
Data are presented as number (%). 
* Data were available in 1021 patients with large and 480 patients with small thrombus burden.




microembolization is suspected to occur. The resulting microvascular obstruction cause 
micro occlusions of capillaries and consequently impair myocardial perfusion.3,7,22 
 Our data shows a higher 30-days and one year all-cause mortality in patients with 
large thrombus burden. Both impaired myocardial perfusion and large thrombus burden 
have been associated to worse outcomes.19,23 Microvascular obstruction may play a role 
in this observation. Residual thrombus burden at the site of the lesion, present in more 
patients with large than in small thrombus burden, has been associated with restenosis 
and stent thrombosis as a response to its thrombogenic contents.24,25 Restenosis and stent 
thrombosis may increase the rate of reinfarction and target-vessel revascularization, which 
may also explain the higher mortality rate. In our study the higher mortality rate can also 
be partly explained by the worse baseline characteristics in patients with large thrombus 
burden, including more often worse TIMI flow. The mortality difference diminished after 
long term follow up.
Impact of thrombus aspiration
In our data we observed that, irrespective of the thrombus burden visible on angiography, 
thrombus aspiration significantly improves myocardial perfusion in STEMI patients. By 
reducing the thrombus burden exposed to the lumen, thrombus aspiration is thought to 
decrease embolization of atherothrombotic material that might obstruct the distal (micro)
vasculature. 
 The Thrombus Aspiration during Percutaneous Coronary Intervention in Acute 
Myocardial Infarction Study (TAPAS) trial demonstrated improved myocardial reperfusion 
after thrombus aspiration, irrespectively of angiographically observed thrombus using 
the definition of Mabin et al.10,26 Other small randomised trials and early meta-analyses 
also showed positive findings of manual thrombus aspiration.27,28 The more recent and 
largest trials to date observed no benefit on hard endpoints. The Thrombus Aspiration 
in ST-Elevation Myocardial Infarction in Scandinavia (TASTE) trial revealed that manual 
thrombus aspiration did not reduce 30-days or 1-year mortality, also not in the subgroup 
of patients with large thrombus burden.11,12 The trial of routine aspiration Thrombectomy 
with PCI versus PCI alone in patients with ST-elevation myocardial infarction undergoing 
primary PCI (TOTAL) confirmed these neutral findings on combined endpoint consisting 
of cardiovascular death, recurrent myocardial infarction, cardiogenic shock or severe 
heart failure at 6 months.13,14 However, ST-segment resolution and distal embolization as 
reflectors of myocardial reperfusion were improved after using thrombus aspiration. No 
difference in outcome was found in subgroup analysis based on the thrombus burden. Still 
bailout thrombus aspiration was performed in 7% of patients after predilatation or after 
stent deployment. Furthermore, the lower rate of GP IIa/IIIb inhibitor administration in the 
thrombus aspiration group may have influenced the thrombus burden. In conclusion, these 
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trials including almost 19,000 patients do not support routine use of manual thrombus 
aspiration. However, it is still unknown whether a strategy of selective thrombus aspiration 
in patients with large thrombus burden might be superior to no thrombus aspiration.
Limitations
The observations of our retrospective analysis should be interpreted with caution and only 
be considered as hypothesis-generating. A large randomized clinical trial could evaluate 
our observations whether a strategy of decreasing thrombus burden is beneficial in both 
small and large thrombus burden in STEMI patients. Results obtained in studies thus far are 
inconclusive. Secondly, our follow-up data is limited to all-cause mortality; no other hard 
endpoints were available. 
Conclusion
This large observational study supports the assumption that large thrombus burden visible 
during angiography is associated with worse angiographic, electrocardiographic and clinical 
outcomes in patients with STEMI. Reducing the thrombus burden by thrombus aspiration 
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